Reporting Owner Activity for James F. Reddoch

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Issuer positions

1

Largest position

Royalty Pharma plc

Disclosed value

$23.3M

Recent activity

Available

Identity 1 fact
Location
New York, NY
SEC ownership signals 1 fact
Owner position summary

Reported owner value

$23,300,586

Estimated from parsed Forms 3/4/5 when the filing discloses holding values.

Issuer count

1

Distinct issuers tied to this reporting owner in parsed SEC filings.

Largest reported position

Royalty Pharma plc (RPRX)

About $23.3M reported in parsed owner filings.

Latest owner filing

30 Sep 2022

Most recent owner-level filing date in the parsed SEC record.

  • Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough pricing and share data.
  • Verify the source filing before treating any owner position as current.
SEC filing record 1 fact
SEC signature
/s/ Sean Weisberg, as Attorney-in-Fact for James F. Reddoch
SEC evidence 1 fact
Source evidence
Open source filing history

Follow Filing Activity

Follow James F. Reddoch and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Reported issuer positions for James F. Reddoch

Insider Transactions Reported by James F. Reddoch:

Sym Company Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .